BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes
- Status
- COMPLETED
- Phase
- PHASE2
A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells
- Status
- UNKNOWN
- Phase
- N/A
Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib for Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)
- Status
- COMPLETED
- Phase
- PHASE2
First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
DNA Methylation and Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DNA Methylation and Arsenic-associated Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2